Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N McAlpine

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2012
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaCheng-Han Lee, Wen-Bin Ou, Adrian Mariño-Enriquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2023
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian CarcinomasKarolin Heinze, Evan S Cairns, Shelby Thornton, et al.
Biopreservation and Biobanking|May 22, 2014
Specimen quality evaluation in Canadian biobanks participating in the COEUR repositoryCécile Le Page, Martin Köbel, Manon de Ladurantaye, et al.
The Journal of Molecular Diagnostics : JMD|September 26, 2024
Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle-Based Blood Test: Performance in a Training and Verification CohortEmily S Winn-Deen, Laura T Bortolin, Daniel Gusenleitner, et al.
Nature Genetics|May 17, 2016
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancerAndrew McPherson, Andrew Roth, Emma Laks, et al.
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
Nature Genetics|April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesYi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
Gynecologic Oncology|January 7, 2020
Therapeutic options for mucinous ovarian carcinomaKylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2022
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classificationEmily F Thompson, Jutta Huvila, Amy Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian CarcinomaPauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2012
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaCheng-Han Lee, Wen-Bin Ou, Adrian Mariño-Enriquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2023
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian CarcinomasKarolin Heinze, Evan S Cairns, Shelby Thornton, et al.
Biopreservation and Biobanking|May 22, 2014
Specimen quality evaluation in Canadian biobanks participating in the COEUR repositoryCécile Le Page, Martin Köbel, Manon de Ladurantaye, et al.
The Journal of Molecular Diagnostics : JMD|September 26, 2024
Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle-Based Blood Test: Performance in a Training and Verification CohortEmily S Winn-Deen, Laura T Bortolin, Daniel Gusenleitner, et al.
Nature Genetics|May 17, 2016
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancerAndrew McPherson, Andrew Roth, Emma Laks, et al.
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
Nature Genetics|April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesYi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
Gynecologic Oncology|January 7, 2020
Therapeutic options for mucinous ovarian carcinomaKylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2022
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classificationEmily F Thompson, Jutta Huvila, Amy Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian CarcinomaPauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
Pageof 19